Article
Molecular docking to investigate HLA-associated idiosyncratic drug reactions
2 Jan 2025
Abstract excerpt
Idiosyncratic drug reactions (IDRs) pose severe threats to patient health. Unlike conventionally dose-dependent side effects, they are unpredictable and more frequently manifest as life-threatening conditions, such as severe cutaneous adverse reactions (SCARs) and drug-induced liver injury (DILI). Some HLA alleles, such as HLA-B*57:01, HLA-B*15:02, and HLA-B*58:01, are known risk factors for adverse reactions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
